Truist Securities Maintains Hold on Cross Country Healthcare, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Cross Country Healthcare (CCRN) but lowered its price target from $17 to $15.
October 21, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on Cross Country Healthcare but lowered its price target from $17 to $15, indicating a more cautious outlook.
The lowering of the price target from $17 to $15 by Truist Securities suggests a more cautious outlook on Cross Country Healthcare's stock performance. This could lead to a negative short-term impact on the stock price as investors may adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100